Astrana Corp (ASTH) Long-Term Debt to Capital Coefficient

Symbol and logo of brand Astrana Health, Inc. (ASTH)

This daily price chart for Astrana Health, Inc. (ASTH) on the GURU.Markets platform reflects the asset's dynamics, with a value of 1.18. The company develops therapy optimization services that are highly sought after by insurers to reduce spending. Efficiency is driven by the centralized supply of medications to medical centers, which minimizes operating expenses. Consequently, Astrana Health, Inc. (ASTH) is building a unique digital healthcare ecosystem, boosting profits through the automation of cost controls.

ASTH Astrana Health: Long-Term Debt to Capital in the range 07/04/2022 - 10/30/2026
Finished products of Astrana Health

Leverage control, reflecting the ratio of liabilities with a maturity of over one year to equity, is critical for long-term investing. By analyzing the current long-term debt-to-equity ratio of Astrana Health, Inc. (ASTH), an investor assesses the financial stability of this value-based healthcare leader, where the balance between debt financing and equity determines the network's ability to scale quality services under strict cost constraints.

Analysis of competing companies

HCA (HCA Holdings) - Long-Term Loans to Capital Ratio|Long-Term Debt to Equity Tenet (THC)|FMS (Fresenius Medical) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital SOLV (Solventum Corporation)|encompasshealth.com (EHC) - Long-Term Liabilities to Capital|Universal Health Services Corp - Long-Term Debt to Capital|DVA - Long-Term Debt to Capital|RDNT (RadNet Corp) - Long-Term Debt to Equity Ratio|OPCH: Long-Term Loans to Capital Ratio|Long-Term Debt to Equity Surgery Partners, Inc.|Long-Term Debt to Equity Ratio premierinc.com (PINC)|Long-Term Debt to Capital EYE|PGNY - Long-Term Liabilities to Capital|Long-Term Debt to Equity Ardent Health Partners Inc ARDT|SEM: Long-Term Debt to Capital Ratio|MD: Long-Term Debt to Equity Ratio|U.S. Physical Therapy - Long-Term Loans to Capital Ratio|PNTG: Long-Term Debt to Capital|Organogenesis Holdings Inc. (ORGO) - Long-Term Debt to Capital|Long-Term Debt to Equity Nutex Health Corp|Auna Corp (AUNA) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Ratio SBC (SBC Medical Group)|Long-Term Loans to Capital Ratio EOLS|Long-Term Debt to Equity Community Health Systems, Inc. CYH|Long-Term Debt to Capital Coefficient SKIN|MediWound, Ltd. - Long-Term Debt to Capital|BTMD - Long-Term Debt to Capital|The Joint Corp. (JYNT) - Long-Term Debt to Equity|Long-Term Debt to Capital Ratio DCGO|PIII (P3 Health Partners, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital Gain Therapeutics Inc.|Long-Term Debt to Equity Ratio EUDA (EUDA Health)|BMGL (baselmedical.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital CLGN (CollPlant Biotechnologies Ltd.)|Long-Term Debt to Capital Coefficient CUPR|Concord Medical - Long-Term Debt to Capital|Long-Term Liabilities to Capital American Shared Hospital Services Inc|MRM: Long-Term Debt to Capital|Avalon GloboCare Corp. (ALBT) - Long-Term Debt to Capital|Long-Term Debt to Equity DIH Holding US, Inc.|Long-Term Debt to Equity XAGE|Long-Term Debt to Equity Ratio NIVF (NewGenIvf)|Long-Term Loans to Capital Ratio ATIP|Long-Term Debt to Capital CMAX (CareMax Medical Group)|Long-Term Debt to Capital Coefficient KDLY|MODV: Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient NVOS (novointegrated.com)|SSY: Long-Term Debt to Capital|BACK - Ratio of Long-Term Indebtedness to Capital